# Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease

> **NCT06356662** · PHASE1 · RECRUITING · sponsor: **The Fourth Affiliated Hospital of Zhejiang University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate

## Key facts

- **NCT ID:** NCT06356662
- **Lead sponsor:** The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-23
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06356662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06356662, "Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06356662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*